An international study has found that genetic variations in human carbohydrate-active enzymes may affect how people with irritable bowel syndrome (IBS) respond to a carbohydrate-reduced diet.

In 2023, the market is anticipated to be valued at USD 26.64 Billion, marking a significant starting point for a decade-long ...

All animals possess some capacity for repairing and replacing the lining of their intestines, a process called intestinal ...

An international study has found that genetic variations in human carbohydrate-active enzymes may affect how people with irritable bowel syndrome ...

Despite its prevalence, treating IBS remains a challenge as symptoms and responses to dietary or pharmacological ...

stroke risk up to 3 years later Health plans at 1 in 5 large companies cover weight-loss drugs for employees GLP-1 ...

Researchers have developed a groundbreaking approach to tackling obesity by targeting fat absorption in the small intestine.

Aaron Wright, Ph.D., partners with colleagues at Weill Cornell Medicine on “out-of-the-box” $5.6 million NIH grant to target ...

A multi-institutional group of researchers led by the Hubrecht Institute and Roche's Institute of Human Biology has developed ...

While most E. coli bacteria are harmless and common, there are some that can make people sick, even leading to serious health conditions that can be fatal.

Researchers have developed strategies to identify regulators of intestinal hormone secretion. In response to incoming food, these hormones are secreted by rare hormone producing cells in the gut and ...

IB-Stim is a non-surgical device that sends gentle electrical impulses into cranial nerve bundles in the ear. There are currently no FDA-approved drug therapies for children with abdominal ...